Rabson-Mendenhall syndrome

From Wikipedia, the free encyclopedia

Rabson-Mendenhall syndrome
Classification and external resources
OMIM 262190

Rabson-Mendenhall syndrome is a rare insulin receptor disorder[1] characterized by severe insulin resistance, developmental abnormalities, and acanthosis nigricans.[2] A hypertrophic pineal gland has been reported in some cases.[3]

Contents

[edit] Clinical presentation

Rabson and Mendenhall described 3 siblings (2 girls, 1 boy) who initially presented with dental and skin abnormalities, abdominal distention, and phallic enlargement.[4] The children demonstrated early dentition, a coarse, senile-appearing facies, and striking hirsutism. An "adult growth of hair of head" at 5 years of age was pictured in the case of one of the girls. In the older girl the genitalia were large enough at the age of 6 months to permit vaginal examination for diagnosis of a left ovarian tumor which was removed soon afterward. The children were mentally precocious. Prognathism and very thick fingernails as well as acanthosis nigricans were also described. Insulin-resistant diabetes developed, and the patients died during childhood of ketoacidosis and intercurrent infections. At necropsy pineal hyperplasia was found in all three.[4]

Biologically, infants display fasting hypoglycemia, postprandial hyperglycemia and hyperinsulinemia, which progress to permanent hyperglycemia and recurrent diabetic ketoacidosis.

[edit] Pathophysiology

Rabson-Mendenhall syndrome has an autosomal recessive pattern of inheritance.
Rabson-Mendenhall syndrome has an autosomal recessive pattern of inheritance.

The condition is transmitted as an autosomal recessive trait, and often affects children of consanguineous parents.[3]

As in leprechaunism, of which Rabson-Mendenhall syndrome represents less severe form, the condition is caused by molecular modification of both alleles of the insulin-receptor gene.

[edit] Treatment

Treatment of Rabson-Mendenhall syndrome with pharmacologic doses of human leptin may result in improvement of fasting hyperglycemia, hyperinsulinemia, basal glucose, and glucose and insulin tolerance.[5]

[edit] References

  1. ^ Kasuga M, Kadowaki T (1994). "Insulin receptor disorders in Japan". Diabetes Res Clin Pract. 24 (Suppl.): 145–151. doi:10.1016/0168-8227(94)90242-9. PMID 7859597. 
  2. ^ Rabson-Mendenhall Syndrome. WebMD.com. Retrieved on 2007-03-17.
  3. ^ a b Rabson-Mendenhall syndrome. orpha.net. Retrieved on 2007-03-17.
  4. ^ a b Rabson S, Mendenhall E (1956). "Familial hypertrophy of pineal body, hyperplasia of adrenal cortex and diabetes mellitus; report of 3 cases". Am J Clin Pathol 26 (3): 283–90. PMID 13302174. 
  5. ^ Cochran E, Young J, Sebring N, DePaoli A, Oral E, Gorden P (2004). "Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome". J Clin Endocrinol Metab 89 (4): 1548–54. doi:10.1210/jc.2003-031952. PMID 15070911.